- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Global Cannabis Launches New Website and Investor Presentation
Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FWB:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce the launch of a new corporate website at www.cannappscorp.com and investor presentation.
Global Cannabis Applications Corp. (“GCAC” or the “Company”) (CSE:APP, FWB:2FA, OTCQB:FUAPF), a leading developer of innovative data technologies for the cannabis industry, is pleased to announce the launch of a new corporate website at www.cannappscorp.com and investor presentation.
“The new corporate website and investor presentation captures the vision and the value of building a world-leading medical cannabis community and supporting database,” said Brad Moore, Chief Executive Officer of GCAC. “We are excited about the opportunity to become the trusted source for all information relating to the medical cannabis community, and we will achieve this goal through advanced technology by offering the best content with the most trusted information on the most interesting and intuitive mobile applications.”
The new GCAC website and Investor Presentation highlights GCAC’s focus on the multibillion-dollar global medical cannabis markets and the noticeable lack of regulatory-approved medical cannabis products beyond its basic leaf form. The regulatory process to approve cannabis products is slow and inefficient, and it takes substantial time to generate data for product approvals through clinical studies. With over 42 governments moving forward with the legalization of medical cannabis, there is a need and an opportunity to fill the medical cannabis data void using advanced technology.
A key focus of both the website and the Investor Presentation is the Citizen Green platform, which uses six core technologies to aggregate anecdotal and clinical trial data to pre-qualify candidates for clinical studies. Pre-qualifying will increase the speed and improve the efficiency of data collection and the approval process for medical cannabis products. As the medical cannabis community grows and the database expands, GCAC’s platform becomes more powerful and the Company expects all stakeholders of medical cannabis will see the value of GCAC’s data and information.
Current shareholders and qualified investors can receive the new corporate presentation by “signing up for updates” on the corporate website at www.cannappscorp.com.
About Global Cannabis Applications Corp.
Global Cannabis Applications Corp. is a global leader in designing, developing, marketing, and acquiring innovative data technologies for the cannabis industry. The Citizen Green platform is the world’s first end-to-end – from patient to regulator – medical cannabis data solution. It uses six core technologies: mobile applications, artificial intelligence, reg tech, smart databases, blockchain and digital reward tokens, to qualify candidates for clinical studies. These technologies facilitate the proliferation of digital conversations by like-minded people in medical cannabis. Managed by digital and cannabis industry experts, GCAC is focused on viral global expansion by providing the best digital experience in the cannabis market.
For more information about the Company, please visit online at www.cannappscorp.com or review its profiles on the SEDAR website (www.sedar.com) and on the Canadian Securities Exchange’s website (www.thecse.com).
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone: 514-5619091
Email: bmoore@cannappscorp.com
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email:
info@cannappscorp.com
www.cannappscorp.com
Forward-Looking Information
This news release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of GCAC. Forward-looking information is based on certain key expectations and assumptions made by the management of GCAC. Although management of the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because GCAC can give no assurance that they will prove to be correct. Forward-looking statements contained in this news release are made as of the date of this news release. GCAC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Click here to connect with Global Cannabis Applications Corp. (CSE:APP, FWB:2FA, OTCQB:FUAPF) for an Investor Presentation
Source: www.thenewswire.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.